HCPCS Level II
J7686
Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
Codes near J7686
These sit next to J7686 in the CMS Level II file. All J codes
- J7681Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7682Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
- J7683Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7684Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7685Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams
- J7699Noc drugs, inhalation solution administered through dme
- J7799Noc drugs, other than inhalation drugs, administered through dme
- J7999Compounded drug, not otherwise classified
- J8498Antiemetic drug, rectal/suppository, not otherwise specified
- J8499Prescription drug, oral, non chemotherapeutic, nos
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 66302-0206-01 | Tyvaso | United Therapeutics Corporation | 28 |
| 66302-0206-02 | Tyvaso | United Therapeutics Corporation | 28 |
| 66302-0206-03 | Tyvaso | United Therapeutics Corporation | 4 |
| 66302-0206-04 | Tyvaso | United Therapeutics Corporation | 4 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.